Friedman J - Search Results

1

Neoadjuvant chemotherapy enhances tumor-specific T cell immunity in patients with HPV-associated oropharyngeal cancer.

Samaniego C, Friedman J, Yang X, Badger C, Shaver T, Samankan S, Thakkar P, Goodman J, Joshi A, Allen CT. Samaniego C, et al. Among authors: friedman j. Head Neck. 2023 Sep;45(9):2294-2302. doi: 10.1002/hed.27463. Epub 2023 Jul 21. Head Neck. 2023. PMID: 37480219

2

Genome-wide identification of novel expression signatures reveal distinct patterns and prevalence of binding motifs for p53, nuclear factor-kappaB and other signal transcription factors in head and neck squamous cell carcinoma.

Yan B, Yang X, Lee TL, Friedman J, Tang J, Van Waes C, Chen Z. Yan B, et al. Among authors: friedman j. Genome Biol. 2007;8(5):R78. doi: 10.1186/gb-2007-8-5-r78. Genome Biol. 2007. PMID: 17498291 Free PMC article.

3

A signal network involving coactivated NF-kappaB and STAT3 and altered p53 modulates BAX/BCL-XL expression and promotes cell survival of head and neck squamous cell carcinomas.

Lee TL, Yeh J, Friedman J, Yan B, Yang X, Yeh NT, Van Waes C, Chen Z. Lee TL, et al. Among authors: friedman j. Int J Cancer. 2008 May 1;122(9):1987-98. doi: 10.1002/ijc.23324. Int J Cancer. 2008. PMID: 18172861

4

Proteomic signatures of epidermal growth factor receptor and survival signal pathways correspond to gefitinib sensitivity in head and neck cancer.

Pernas FG, Allen CT, Winters ME, Yan B, Friedman J, Dabir B, Saigal K, Mundinger GS, Xu X, Morris JC, Calvo KR, Van Waes C, Chen Z. Pernas FG, et al. Among authors: friedman j. Clin Cancer Res. 2009 Apr 1;15(7):2361-72. doi: 10.1158/1078-0432.CCR-08-1011. Epub 2009 Mar 24. Clin Cancer Res. 2009. PMID: 19318490 Free PMC article.

5

ΔNp63 versatilely regulates a Broad NF-κB gene program and promotes squamous epithelial proliferation, migration, and inflammation.

Yang X, Lu H, Yan B, Romano RA, Bian Y, Friedman J, Duggal P, Allen C, Chuang R, Ehsanian R, Si H, Sinha S, Van Waes C, Chen Z. Yang X, et al. Among authors: friedman j. Cancer Res. 2011 May 15;71(10):3688-700. doi: 10.1158/0008-5472.CAN-10-3445. Cancer Res. 2011. PMID: 21576089 Free PMC article.

6

Anti-PD-L1 Efficacy Can Be Enhanced by Inhibition of Myeloid-Derived Suppressor Cells with a Selective Inhibitor of PI3Kδ/γ.

Davis RJ, Moore EC, Clavijo PE, Friedman J, Cash H, Chen Z, Silvin C, Van Waes C, Allen C. Davis RJ, et al. Among authors: friedman j. Cancer Res. 2017 May 15;77(10):2607-2619. doi: 10.1158/0008-5472.CAN-16-2534. Epub 2017 Mar 31. Cancer Res. 2017. PMID: 28364000 Free PMC article.

7

Dose-dependent enhancement of T-lymphocyte priming and CTL lysis following ionizing radiation in an engineered model of oral cancer.

Morisada M, Moore EC, Hodge R, Friedman J, Cash HA, Hodge JW, Mitchell JB, Allen CT. Morisada M, et al. Among authors: friedman j. Oral Oncol. 2017 Aug;71:87-94. doi: 10.1016/j.oraloncology.2017.06.005. Epub 2017 Jun 10. Oral Oncol. 2017. PMID: 28688697 Free PMC article.

8

Resistance to CTLA-4 checkpoint inhibition reversed through selective elimination of granulocytic myeloid cells.

Clavijo PE, Moore EC, Chen J, Davis RJ, Friedman J, Kim Y, Van Waes C, Chen Z, Allen CT. Clavijo PE, et al. Among authors: friedman j. Oncotarget. 2017 Jun 11;8(34):55804-55820. doi: 10.18632/oncotarget.18437. eCollection 2017 Aug 22. Oncotarget. 2017. PMID: 28915554 Free PMC article.

9

PD-1 blockade reverses adaptive immune resistance induced by high-dose hypofractionated but not low-dose daily fractionated radiation.

Morisada M, Clavijo PE, Moore E, Sun L, Chamberlin M, Van Waes C, Hodge JW, Mitchell JB, Friedman J, Allen CT. Morisada M, et al. Among authors: friedman j. Oncoimmunology. 2017 Nov 27;7(3):e1395996. doi: 10.1080/2162402X.2017.1395996. eCollection 2018. Oncoimmunology. 2017. PMID: 29399393 Free PMC article.

10

Nanocomplex-based TP53 gene therapy promotes anti-tumor immunity through TP53- and STING-dependent mechanisms.

Moore EC, Sun L, Clavijo PE, Friedman J, Harford JB, Saleh AD, Van Waes C, Chang EH, Allen CT. Moore EC, et al. Among authors: friedman j. Oncoimmunology. 2018 May 7;7(7):e1404216. doi: 10.1080/2162402X.2017.1404216. eCollection 2018. Oncoimmunology. 2018. PMID: 29900037 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,109 results

Search Page

Filters